RetinalGenix Technologies (RTGN) Capital Expenditures (2021)
RetinalGenix Technologies (RTGN) reported Capital Expenditures of $12139.0 for Q1 2021.
RetinalGenix Technologies (RTGN) Capital Expenditures (2021) Analysis & Trends
RetinalGenix Technologies (RTGN) has 1 years of Capital Expenditures data on file, last reported at $12139.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | 64.90 Mn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 178.00 Mn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 76.60 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -85.46 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 12,139.00 |
| Mar 31, 2021 | 12,139.00 |